Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOSYN (piperacillin/tazobactam) in pediatric patients with febrile neutropenia
jRCT1080223102Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Feb 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of piperacillin + tazobactam in febrile neutropenia (FN), sponsored by Taiho Pharmaceutical Co., Ltd. Started Feb 2016; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on jRCT1080223102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223102.